Déclaration d'accessibilité Sauter la navigation
  • Ressources
  • Journalistes
  • Relations investisseurs
  • Webdiffusion
  • English
  • mon CNW 
    • Ouvrir une session
    • Créez un compte
  • Ouvrir une session
  • Inscription
  • Envoyer
Cision Canada
  • Nouvelles
  • Produits
  • Nous joinder
Recherche
When typing in this field, a list of search results will appear and be automatically updated as you type.

Rechercher votre contenu...

Aucun résultat trouvé. Modifiez les termes de votre recherche et réessayez.

News Releases

view all
    Recherche avancée
    • Communiqués
        • Parcourir les communiqués

        • Tous les communiqués de presse
        • Tous les communiqués de sociétés publiques
        • Parcourir tous les communiqués

        • Galerie multimédia

        • Tous les communiqués avec multimédia
        • Tous les communiqués avec photos
        • Tous les communiqués avec vidéos
        • Voir toute la Galerie multimédia

        • Sujets d'actualité

        • Voir tous les sujets d'actualité
    • Affaires
        • Affaires Générales

        • Activités d'externalisation
        • Annonces relatives au personnel
        • Communiqués salon professionnel
        • Enquêtes, sondages et recherches
        • Expansion d'entreprise
        • Immobilier commercial
        • Immobilier résidentiel
        • Investissement socialement responsable
        • Licenciement
        • Nécrologie
        • Nouveaux produits et services
        • Récompenses
        • Ressources humaines et gestion des effectifs
        • Résultats financiers
        • Services aux petites entreprises
        • Transactions immobilières
        • Survol, Affaires Générales

        • Voir tout Affaires Générales

        • Divertissement et médias

        • Art
        • Divertissement
        • Film
        • Livres
        • Magazines
        • Musique
        • Publicité
        • Radio & Baladodiffusion
        • Services de publication et d'information
        • Télévision
        • Survol, Divertissement et médias

        • Voir tout Divertissement et médias

        • Secteur de l’automobile et du transport

        • Aérospatiale, défense
        • Automobile
        • Chaîne logistique / Logistique
        • Compagnies aériennes & Aviation
        • Fret aérien
        • Maritime & Construction navale
        • Tourisme et Voyages
        • Transport, camionnage et de chemin de fer
        • Transports routiers
        • Voies ferrées et transport intermodal
        • Survol, Secteur de l’automobile et du transport

        • Voir tout Secteur de l’automobile et du transport

        • Services financiers et investissements

        • Accords financiers
        • Acquisitions, fusions et rachats
        • Activisme actionnarial
        • Annonces de conférence de presse
        • Assurance
        • Capital de risque
        • Coentreprises
        • Contrats
        • Cryptomonnaie
        • Dividendes
        • Émission d'actions
        • Faillite
        • Fonds communs
        • Fractionnement d'actions
        • Immobilier
        • Nouvelles et dossiers
        • Obligations et actions
        • Opinions d'investissement
        • Placement privé
        • Prévisions de résultats & projections
        • Rapports des ventes
        • Restructuration & recapitalisation
        • Résultats financiers
        • Services bancaires & financiers
        • Survol, Services financiers et investissements

        • Voir tout Services financiers et investissements

        • Technologies des affaires

        • Analyse de données
        • Automatisation de la conception électronique
        • Chaîne de blocs
        • Commerce électronique
        • Composants électroniques
        • Informatique et électronique
        • Logiciel informatique
        • Matériel informatique
        • Nanotechnologie
        • Périphériques
        • Réseaux
        • Sécurité haute technologie
        • Semi-conducteurs
        • Technologie de radiodiffusion
        • Technologie financière
        • Technologie Internet
        • Survol, Technologies des affaires

        • Voir tout Technologies des affaires

    • Sciences et technologie
        • Énergie et ressources naturelles

        • Chimie
        • Commodités
        • Découvertes en matière de pétrole et de gaz
        • Énergies alternatives
        • Fabrication générale
        • Gaz
        • Mines
        • Mines & Métaux
        • Pétrole & Énergie
        • Services d'eau
        • Services d'électricité
        • Survol, Énergie et ressources naturelles

        • Voir tout Énergie et ressources naturelles

        • Environnement

        • Catastrophes naturelles
        • Conservation & Recyclage
        • Politique environnementale
        • Problèmes environnementaux
        • Produits et services environnementaux
        • Technologie verte
        • Survol, Environnement

        • Voir tout Environnement

        • Industries lourdes et manufacturières

        • Aéronautique & Défense
        • Agriculture
        • Chimie
        • Construction & Bâtiment
        • CVC (Chauffage, ventilation et climatisation)
        • Fabrication générale
        • Machinerie
        • Machines-outils, travail des métaux et métallurgie
        • Métaux précieux
        • Mine
        • Mines & Métaux
        • Papier, produits forestiers et conteneurs
        • Tabac
        • Textiles
        • Survol, Industries lourdes et manufacturières

        • Voir tout Industries lourdes et manufacturières

        • Technologie de consommation

        • Analyse de données
        • Chaîne de blocs
        • Chaîne logistique / Logistique
        • Commerce électronique
        • Communications sans fil
        • Cryptomonnaie
        • Divertissement mobile
        • Électronique de consommation
        • Infonuagique / Internet des objets
        • Informatique et électronique
        • Intelligence artificielle
        • Jeux électroniques
        • Logiciel informatique
        • Matériel informatique
        • Médias sociaux
        • Multimédia & Internet
        • Périphériques
        • STIM (Science, technologie, ingénierie, mathématiques)
        • Technologie financière
        • Survol, Technologie de consommation

        • Voir tout Technologie de consommation

        • Télécommunications

        • Carrières et services
        • Communications sans fil
        • Divertissement mobile
        • Équipement de télécommunication
        • Industrie de la télécommunication
        • Périphériques
        • Réseaux
        • VoIP (voix sur IP)
        • Survol, Télécommunications

        • Voir tout Télécommunications

    • Santé et style de vie
        • Divertissement et médias

        • Art
        • Divertissement
        • Film
        • Livres
        • Magazines
        • Musique
        • Publicité
        • Radio & Baladodiffusion
        • Services de publication et d'information
        • Télévision
        • Survol, Divertissement et médias

        • Voir tout Divertissement et médias

        • Produits de consommation et vente au détail

        • Aliments biologiques
        • Aliments et boissons
        • Animaux et animaux domestiques
        • Bières, vins et spiritueux
        • Bijoux
        • Boissons
        • Boissons non-alcoolisées
        • Cannabis
        • Commerce
        • Jouets
        • Ménages, Consommateurs, Cosmétiques
        • Meubles et ameublement
        • Mode
        • Produits cosmétiques et soins personnels
        • Produits d'entretien domestique
        • Produits de bureau
        • Rappels de produit
        • Rénovation domiciliaire
        • Restaurants
        • Services nuptiaux
        • Supermarchés
        • Survol, Produits de consommation et vente au détail

        • Voir tout Produits de consommation et vente au détail

        • Santé

        • Approbation médicale internationale
        • Assurance santé
        • Biométrique
        • Biotechnologie
        • Conditionnement physique / Mieux-être
        • Contrôle des infections
        • Dentisterie
        • Équipement médical
        • Essais cliniques & de Découvertes Médicales
        • Homologation de la FDA
        • Médecines complémentaires
        • Pharmaceuticals médicaux
        • Pharmaceutiques
        • Santé mentale
        • Soins de santé & hôpitaux
        • Survol, Santé

        • Voir tout Santé

        • Sports

        • Équipements et accessoires de sport
        • Événements sportifs
        • Plein air, camping, randonnée pédestre
        • Sports en général
        • Survol, Sports

        • Voir tout Sports

        • Tourisme et Voyages

        • Hôtels et stations
        • Hôtels et stations
        • Industrie du voyage
        • Loisirs et tourisme
        • Parcs d'attraction et attractions touristiques
        • Plein air, camping, randonnée pédestre
        • Trafic aérien de passagers
        • Survol, Tourisme et Voyages

        • Voir tout Tourisme et Voyages

    • Politique et intérêt public
        • Politique et intérêt public

        • Actualités, tendances, analyses économiques
        • Actualités syndicales
        • Bien-être de l'animal
        • But non lucratif
        • Catastrophes naturelles
        • Direction & Agence fédérale exécutif
        • Éducation
        • Environnement
        • Gouvernement européen
        • Homologation de la FDA
        • Législation fédérale et nationale
        • Opinion du groupe de défense des droits
        • Politique commerciale
        • Politique étrangère
        • Politique fédérale
        • Politique intérieure
        • Politique municipale
        • Politique provinciale
        • Questions juridiques
        • Responsabilité sociale de l'entreprise
        • Sécurité intérieure
        • Sécurité publique
        • Survol, Politique et intérêt public

        • Voir tout Politique et intérêt public

    • Société
        • Société

        • Actualités liées aux Afro-américains
        • Actualités liées aux Asiatiques
        • Actualités liées aux enfants
        • Actualités liées aux femmes
        • Actualités liées aux personnes handicapées
        • Actualités orientées vers les hispaniques
        • Anciens combattants
        • Autochtones, Premières Nations et Amérindiens
        • Diversité, équité & inclusion
        • Intérêt des hommes
        • Lesbienne, Homosexuel, Bisexuel
        • Personnes du troisième âge
        • Religion
        • Survol, Société

        • Voir tout Société

    • Recherche avancée
    • Découvrir la plateforme
    • Planifier des campagnes
    • Créer avec l'IA
    • Diffuser des communiqués
    • Mesurer vos résultats
    • Amplifier le contenu
    • Devenir un client
    • Demandez une démo
    • Bureaux d'édition
    • Partenariats
    • Renseignements généraux
    • Médias
    • Bureaux Mondiaux
    • Hamburger menu
    • Cision Canada
    • Envoyer
    • EN
      • Téléphone

      • 877-269-7890 de 8h00 à 22h00

      • Contactez Cision
      • Contactez Cision

        877-269-7890
        de 8h00 à 22h00

    • Rechercher votre contenu...

      Aucun résultat trouvé. Modifiez les termes de votre recherche et réessayez.

      News Releases

      view all
      Close menu
    • Nouvelles
    • Produits
    • Nous joinder
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • 3 Communiqués
      • 5 Affaires
      • 5 Sciences et technologie
      • 5 Santé et style de vie
      • 1 Politique et intérêt public
      • 1 Société
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • Découvrir la plateforme
      • Planifier des campagnes
      • Créer avec l'IA
      • Diffuser des communiqués
      • Mesurer vos résultats
      • Amplifier le contenu
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • Devenir un client
      • Demandez une démo
      • Bureaux d'édition
      • Partenariats
      • Renseignements généraux
      • Médias
      • Bureaux Mondiaux
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      Close submenu (Communiqués) Communiqués
      • Parcourir les communiqués
      • Galerie multimédia
      • Sujets d'actualité
      Close submenu (Affaires) Affaires
      • Affaires Générales
      • Divertissement et médias
      • Secteur de l’automobile et du transport
      • Services financiers et investissements
      • Technologies des affaires
      Close submenu (Sciences et technologie) Sciences et technologie
      • Énergie et ressources naturelles
      • Environnement
      • Industries lourdes et manufacturières
      • Technologie de consommation
      • Télécommunications
      Close submenu (Santé et style de vie) Santé et style de vie
      • Divertissement et médias
      • Produits de consommation et vente au détail
      • Santé
      • Sports
      • Tourisme et Voyages
      Close submenu (Politique et intérêt public) Politique et intérêt public
      • Politique et intérêt public
      Close submenu (Société) Société
      • Société

      Dialogue Announces First Quarter 2021 Results

      Dialogue logo (CNW Group/Dialogue Health Technologies Inc.)

      Nouvelles fournies par

      Dialogue Health Technologies Inc.

      10 mai, 2021, 17:00 ET

      Partager cet article

      Partager cet article


      Continued momentum drives Yr/Yr Revenue growth of 321%

      MONTREAL, May 10, 2021 /CNW Telbec/ - Dialogue Health Technologies Inc. (TSX: CARE) ("Dialogue" or the "Company"), Canada's premier health and wellness virtual healthcare platform, today announced its financial and operational results for the three months ended March 31, 2021. Financial references are in Canadian dollars unless otherwise indicated.

      "Q1 2021 was truly a banner quarter for Dialogue, we landed a number of marquee customers, completed a $100 million Initial Public Offering and maintained our growth trajectory," said Cherif Habib, CEO of Dialogue. "We remain focused on executing on our Integrated Health Platform™ strategy to meet the increasing health and wellness needs of our customers."

      Q1 2021 Financial Highlights
      (All capitalized terms not defined herein, shall have the meaning ascribed to them in the Management's Discussion and Analysis for the three months ending March 31, 2021; Comparison periods in each case are the three months ended March 31, 2020, unless otherwise stated)

      • Annual Recurring and Reoccurring Revenue grew to $65.3 million with new customer wins, including a major telecom, two top 30 law firms and a brand name consumer retailer, as well as, program expansions with existing customers, including the Mental Health and Employee Assistance Program ("EAP") offerings to existing instances of Primary Care
      • Revenue increased 4X to $15.2 million, compared to $3.6 million, due to growth in Members, including Members from agreements with strategic distribution partners, an increase in attach rate, as well as the acquisition of Optima Global Health Inc. ("Optima") on October 1, 2020
      • Members grew to close to 1.3 million an increase of 335,000 or 35.9% compared to December 31, 2020. Annual Recurring and Reoccurring Revenue grew to $65.3 million as of March 31, 2021, compared to $58.5 million as of December 31, 2020
      • Attach Rate grew to 1.08, compared to 1.07 as at December 31, 2020, as customers continue to expand the services they offer Members from Dialogue's Integrated Health Platform™ ("IHP"), of primary care, Mental Health and EAP offering
      • Gross Margin was 41.5%, compared to 43.7%, due to the lower margin profile of the Optima acquisition
      • Adjusted EBITDA1 loss was $5.0 million, an increase of $0.4 million, due to higher expenses, partially offset by higher gross profit
      • Total Comprehensive Loss was $230.9 million, compared to $5.0 million, due primarily to the one-time non-cash accounting charge of $225.5 million related to the increase in the fair market value conversion feature of the Class B preferred shares. This charge was a result of the increase in the value of the Common Shares of the Company prior to the IPO. The remaining net increase of $0.4 million was due to an  increase in operating expenses, from investments in product and development, sales and marketing and general and administrative costs, and the acquisition of Optima, which was partially offset by higher gross margin
      • Cash and Cash Equivalents were $129.0 million as of March 31, 2021 compared to $42.1 million as of December 31, 2020, the increase was primarily the result of net proceeds from the initial public offering of $90.6 million

      Q1 2021 Business Highlights

      • The Company strengthened its IHP strategy, integrating the EAP program into the same intuitively designed member application to provide a one-stop solution to improve both the HR and member experience, allowing members to schedule a consultation regarding a physical health, mental health, and financial support issue all in minutes, within the same application
      • The Company has started transitioning customers of Optima, a leading Canadian EAP provider acquired in 2020, to its virtual care solution, to improve the customer and user experience 
      • The Company launched its new proprietary wellness intake process for members that optimized 6,000 intake questions to more quickly match members with practitioners which results in more than 900 dispatch possibilities generated from only five questions, ensuring our members can schedule an appointment within minutes
      • As part of the Company's commitment to the Accessibility for Ontarians with Disabilities Act, it updated its member application to comply with WCAG 2.0 Level AA, so its services are accessible for all users, including those with visual, hearing, motor and cognitive challenges
      • The Company launched its new content management system capability within its application, allowing members to view relevant wellness-related articles and tips without leaving the Dialogue application enabling the Company's experts to engage members with proprietary content
      • The Company launched a new OHS Portal for its German business to allow clients to digitize and streamline the occupational health & safety experience and better connect the Company's safety experts to clients 
      • The Company closed its $100 million initial public offering and its common shares commenced trading on the Toronto Stock Exchange under the symbol "CARE"
      • The Company earned a Best Workplaces for Women recognition and the Company ranked # 15 on the list of Best Workplaces in Canada.

      Notice of Conference Call
      Dialogue will host a live video webinar Tuesday, May 11, 2021 at 10:00 AM ET to discuss its financial results. Mr. Cherif Habib, CEO, and Mr. Navaid Mansuri, CFO, will co-chair the call. All interested parties can join the event at https://us02web.zoom.us/webinar/register/WN_PAT2ougQQXS7kvgiM2jh1w. A link to the live event will be available on the Investors Events page on the Company's website at www.investors.dialogue.co. The presentation will be accompanied by slides, which will be available on the screen view and will be made available following the webinar on  the Company's website. Please connect at least 15 minutes prior to the event to ensure adequate time for any software download of Zoom that may be required to attend the event. Listeners that prefer to dial in by phone may do so by accessing the same web link and the dial in details will be provided by email upon registration.

      1Non-IFRS Financial Measures

      This press release makes reference to certain non IFRS measures, such as "EBITDA" (which stands for net profit or loss before net financing expenses, income taxes, depreciation of property and equipment, amortization of intangible assets and amortization of right-of-use assets) and "Adjusted EBITDA" (which stands for adjusted net profit or loss before net financing expenses, income taxes, depreciation of property and equipment, amortization of intangible assets, amortization of right-of-use assets, transaction costs, acquisition costs, change in fair value of conversion feature and share-based payments expense). These measures are not recognized under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information as reported under IFRS. Management also believes that other users, such as securities analysts, investors and other interested parties, frequently use non-IFRS measures, particularly in the evaluation of issuers.

      Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of management compensation. Where applicable, we provide a clear quantitative reconciliation from the non-IFRS financial measures to the most directly comparable measure calculated in accordance with IFRS.

      The following table reconciles net loss to Adjusted EBITDA loss for the three months ended March 31, 2021 and March 31, 2020:

      DIALOGUE HEALTH TECHNOLOGIES INC.

      ADJUSTED EBITDA

      FOR THE THREE MONTH ENDED MARCH 31, 2021 AND 2020

       
               

      (in thousands of CAD)

       

      Three Months Ended March 31

         

      2021

       

      2020

      Net loss

       

      $

      (231,235)

      $

      (4,938)

      Net financing expenses

       

      188

       

      55

      Income taxes

       

      (105)

       

      -

      EBIT

       

      (231,152)

       

      (4,883)

      Depreciation of property and equipment

       

      109

       

      108

      Amortization of intangible assets

       

      330

       

      76

      Amortization of right-of-use assets

       

      148

       

      120

      EBITDA

       

      (230,565)

       

      (4,579)

      Share-based payments expense

       

      97

       

      73

      Acquisition costs

       

      43

       

      -

      Change in fair value of conversion feature

       

      225,417

       

      (67)

      Adjusted EBITDA

       

      $

      (5,008)

      $

      (4,573)

      About Dialogue
      Incorporated in 2016, Dialogue is Canada's premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through our team of health professionals, we serve employers and organizations who have an interest in the health and well-being of their employees, members and their families. Our Integrated Health Platform™ is a one-stop healthcare hub that centralizes all of our programs in a single, user-friendly application, providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet.

      Forward-Looking Information

      This release includes "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking information may relate to our financial outlook (including revenues and Adjusted EBITDA), and anticipated events or results and may include information regarding our financial position, business strategy, growth strategies, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives.

      In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management's current beliefs, expectations, estimates and projections regarding future events and operating performance.

      Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Dialogue as of the date of this release, are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ, possibly materially, from those indicated by the forward-looking statements include, but are not limited to, the risk factors identified under "Risk Factors" in the Company's latest annual information form, and in other periodic filings that the Company has made and may make in the future with the securities commissions or similar regulatory authorities in Canada, all of which are available under the Company's SEDAR profile at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect Dialogue. However, such risk factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. Dialogue undertakes no obligation to publicly update any forward-looking statement, except as required by applicable securities laws.

      Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not currently known to us or that we currently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, you should not place undue reliance on forward-looking information. The forward-looking information represents our expectations as of the date of this earnings release (or as the date it is otherwise stated to be made) and is subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable Canadian securities laws. All of the forward-looking information contained in this earnings release is expressly qualified by the foregoing cautionary statements.

      DIALOGUE HEALTH TECHNOLOGIES INC.

      INTERIM CONDENSED CONSOLIDATED STATEMENT OF NET LOSS AND OTHER COMPREHENSIVE LOSS

      FOR THE THREE MONTH ENDED MARCH 31, 2021 AND 2020

               
               
         

      Three Months Ended March 31

         

      2021

       

      2020

               

      Revenue

       

      $

      15,238,417

       

      $

      3,618,361

      Cost of services

       

      8,907,939

       

      2,035,968

      Gross profit

       

      6,330,478

       

      1,582,393

               

      Operating Expenses

             

      General and administrative

       

      7,583,676

       

      3,436,472

      Sales and marketing 

       

      2,398,271

       

      1,873,237

      Product and development

       

      1,987,363

       

      1,149,326

      Share-based payments expense

       

      96,701

       

      73,199

         

      12,066,011

       

      6,532,234

               

      Operating loss

       

      (5,735,533)

       

      (4,949,841)

               

      Other expenses

             

      Change in fair value of conversion feature

       

      225,416,590

       

      (66,916)

      Net financing expenses

       

      187,638

       

      54,679

         

      225,604,228

       

      (12,237)

               

      Net Loss before income taxes

       

      $

      (231,339,761)

       

      $

      (4,937,604)

      Deferred income tax recovery

       

      104,639

       

      -

      Net loss

       

      $

      (231,235,122)

       

      $

      (4,937,604)

               

      Other comprehensive (loss):

             
               

      Items that may be reclassified subsequently to net loss

         

      Foreign currency translation

       

      310,534

       

      (93,870)

      Total comprehensive loss

       

      $

      (230,924,588)

       

      $

      (5,031,474)

               

      Loss per share-Basic and Diluted

       

      (3.55)

       

      (0.44)

      DIALOGUE HEALTH TECHNOLOGIES INC.

      INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

                   
                   
             

      As at 

             

      March 31, 2021

       

      December 31, 2020

                   

      Assets

                 

      Current assets

                 

      Cash and cash equivalents

           

      $

      129,021,671

       

      $

      42,067,100

      Trade and other receivables

           

      12,598,901

       

      11,358,615

      Asset held for sale

           

      -

       

      909,541

      Prepaid expenses

           

      1,201,057

       

      745,673

             

      142,821,629

       

      55,080,929

                   

      Property and equipment

           

      1,096,981

       

      1,019,406

      Right-of-use assets

           

      1,923,090

       

      1,687,434

      Intangible assets

           

      5,627,205

       

      5,472,196

      Goodwill

           

      3,104,284

       

      3,114,927

             

      $

      154,573,189

       

      $

      66,374,892

                   

      Liabilities

                 

      Current liabilities

                 

      Trade payable and accrued liabilities

           

      $

      9,582,072

       

      $

      7,489,083

      Unearned revenue

           

      975,849

       

      476,619

      Liability related to asset held for sale

           

      -

       

      430,110

      Current portion of contigent consideration payable

           

      1,330,436

       

      1,379,501

      Current portion of long-term debt

           

      398,020

       

      398,020

      Current portion of lease liabilities

           

      578,484

       

      524,618

             

      12,864,861

       

      10,697,951

                   
                   

      Non-current portion of lease liabilities

           

      1,246,035

       

      1,086,720

      Non-current portion of long-term debt

           

      1,359,812

       

      1,459,407

      Non-current portion of contingent consideration payable

         

      790,654

       

      523,499

      Redeemable Class B preferred shares

           

      -

       

      82,805,661

      Deferred Income Tax liability

           

      872,291

       

      976,890

      Conversion option on Redeemable Class B preferred shares

       

      -

       

      92,755

             

      17,133,653

       

      97,642,883

                   

      Commitments and contingencies

           

      -

       

      -

                   

      Shareholders' equity (deficit)

                 

      Share capital

           

      458,425,534

       

      18,890,120

      Equity reserve

           

      911,774

       

      815,073

      Cumulative translation adjustment

           

      (94,629)

       

      (405,163)

      Deficit

           

      (321,803,143)

       

      (50,568,021)

             

      137,439,536

       

      (31,267,991)

                   
             

      $

      154,573,189

       

      $

      66,374,892

      DIALOGUE HEALTH TECHNOLOGIES INC.

      INTERIM CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

      FOR THE THREE MONTH ENDED MARCH 31, 2021 AND 2020

       
                   
             

      Three Months Ended March 31

             

      2021

       

      2020

                   

      Operating activities

                 

      Net loss

           

      $

      (231,235,122)

       

      $

      (4,937,604)

      Items not affecting cash:

                 

      Write-off of leasehold improvements

           

      -

       

      157,715

      Income tax recovery

           

      (104,639)

       

      -

      Change in conversion feature on preferred shares

           

      225,416,590

       

      (66,916)

      Depreciation of property and equipment

           

      109,215

       

      107,820

      Amortization of right-of-use assets

           

      147,983

       

      120,200

      Net financing expenses

           

      254,109

       

      128,522

      Amortization of intangible assets

           

      330,381

       

      75,558

      Share-based payments expense

           

      96,701

       

      73,199

             

      (4,984,782)

       

      (4,341,506)

                   

      Net changes in non-cash operating working capital items:

                 

      Trade and other receivables

           

      (1,240,286)

       

      (895,842)

      Prepaid expenses

           

      (455,384)

       

      77,511

      Trade payable and accrued liabilities

           

      2,092,990

       

      1,491,676

      Unearned revenue

           

      499,230

       

      39,781

      Interest paid

           

      (13,807)

       

      (16,154)

             

      (4,102,039)

       

      (3,644,534)

                   

      Investing activities

                 

      Purchase of property and equipment

           

      (186,789)

       

      (93,828)

      Purchase of intangible assets

           

      (18,471)

       

      -

      Sale of Asset held for sale

           

      909,541

       

      -

      Botfront Acquisition

           

      (291,800)

       

      -

             

      412,481

       

      (93,828)

                   

      Financing activities

                 

      Issuance of shares

           

      100,008,000

       

      -

      Share issue costs

           

      (9,371,189)

       

      -

      Options Exercised

           

      392,441

       

      17,451

      Repayment of liability related to asset held for sale

           

      (430,110)

       

      -

      Repayment of long-term debt

           

      (100,005)

       

      -

      Repayment of lease liabilities

           

      (165,542)

       

      (144,258)

             

      90,333,595

       

      (126,807)

                   

      Effect of foreign currency translation

           

      310,534

       

      (93,870)

      Net increase in cash and cash equivalents

           

      86,954,571

       

      (3,959,039)

      Cash and cash equivalents—beginning of quarter

           

      42,067,100

       

      24,611,895

      Cash and cash equivalents—end of quarter

           

      $

      129,021,671

       

      $

      20,652,856

      SOURCE Dialogue Health Technologies Inc.

      Investor relations, Navaid Mansuri, Chief Financial Officer, [email protected]; Media Relations, Jean-Christophe de Le Rue, Director of Public and Government Relations, [email protected] / 613-806-0671

      Modal title

      Profil de l'entreprise

      Dialogue Health Technologies Inc.

        Autres communiqués de la compagnie

      • Dialogue lance le Profil de Santé pour aider les Canadiens à comprendre leurs risques de santé et à agir

      • Le bien-être des employés canadiens continue de décliner alors que les employeurs peinent à mesurer et à améliorer les résultats

      • Une étude révèle que les soins virtuels de santé mentale financés par l'employeur pourraient faire économiser 22 milliards de dollars par année au Canada

      Communiquer avec PR Newswire

      • 877-269-7890
        De 7 h 30 à 18 h 30 (HE)
      • Devenir un client
      • Demander une démo
      • Bureaux d'édition
      • Partenariats
      • Renseignements généraux
      • Médias
      • Bureaux mondiaux

      Produits

      • Découvrez la plateforme
      • Planifier des campagnes
      • Créer avec l'IA
      • Diffuser des communiqués
      • Mesurer vos résultats
      • Amplifiez le contenu
      • Relations investisseurs

      À propos

      • À propos de Cision
      • Carrières
      • Énoncé d'accessibilité

      Services

      • Toutes les nouvelles
      • Connexion à la plateforme
      • mon CNW
      • Protection des données

      Ne pas vendre ou partager mes informations personnelles:

      • Soumettre à [email protected] 
      • Appelez gratuitement notre département de la protection de la vie privée: 877-297-8921

      Communiquer avec Cision

      Produits

      À propos

      Services
      • Toutes les nouvelles
      • Comms Cloud Nouvelle Génération
      • Cision Communications Cloud®
      • Plateforme
      • mon CNW
      877-269-7890
      de 8h00 à 22h00
      • Modalités d'utilisation
      • Politique sur la sécurité des données
      • Plan du site
      • Paramètres de cookies
      • Énoncé d'accessibilité
      © Groupe CNW Ltée 2026 Tous droits réservés. Une société Cision.